StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.27+0.30 (+1.07%)

Close on Nov 17, 2026Market cap $1.68BP/E –Yield –

Kestra Medical Technologies profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Kestra Medical Technologies's profit margin for the twelve months ending Jul 31, 2026 was -140.4%. For fiscal 2026 it was -138.4%, against -190.3% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Apr 30, 2026-138.4%+51.9
FY2025Apr 30, 2025-190.3%+148.1
FY2024Apr 30, 2024-338.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jul 31, 2026-142.3%−9.0
Q4 FY2026CQ1 2026Apr 30, 2026-135.6%+166.4
Q3 FY2026CQ4 2025Jan 31, 2026-139.2%+3.4
Q2 FY2026CQ3 2025Oct 31, 2025-145.3%−6.8
Q1 FY2026CQ2 2025Jul 31, 2025-133.3%+22.2
Q4 FY2025CQ1 2025Apr 30, 2025-302.1%–
Q3 FY2025CQ4 2024Jan 31, 2025-142.5%–
Q2 FY2025CQ3 2024Oct 31, 2024-138.5%–
Q1 FY2025CQ2 2024Jul 31, 2024-155.6%–

More Kestra Medical Technologies figures

See a number that looks wrong?